{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:15:53Z","timestamp":1768288553798,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"am","delay-in-days":387,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.transproceed.2021.08.062","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T22:24:59Z","timestamp":1641939899000},"page":"293-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Outcomes of Everolimus With Reduced-Dose Tacrolimus vs Mycophenolate Mofetil With Standard-Dose Tacrolimus in De Novo ABO-Incompatible Kidney Transplant Recipients: 1-Year Follow-up"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0245-2994","authenticated-orcid":false,"given":"Akihiro","family":"Kosoku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2021-0673","authenticated-orcid":false,"given":"Tomoaki","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2021.08.062_bib0001","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","author":"Lamb","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0002","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1600-6143.2011.03539.x","article-title":"Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success","volume":"11","author":"Lodhi","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0003","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0004","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5500\/wjt.v6.i1.183","article-title":"Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation","volume":"6","author":"Baroja-Mazo","year":"2016","journal-title":"World J Transplant"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0005","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1111\/j.1600-6143.2005.01063.x","article-title":"Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients","volume":"5","author":"V\u00edtko","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0006","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1600-6143.2010.03129.x","article-title":"Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients","volume":"10","author":"Jr","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0007","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/ajt.14090","article-title":"Efficacy and safety of everolimus plus low-dose tacrolimus versus mycophenolate mofetil plus standard-dose tacrolimus in de novo renal transplant recipients: 12-month data","volume":"17","author":"Qazi","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0008","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.kint.2019.01.041","article-title":"An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients","volume":"96","author":"Sommerer","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0009","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/ajt.15480","article-title":"Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study","volume":"19","author":"Berger","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0010","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0011","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0012","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0013","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/ctr.12624","article-title":"De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation","volume":"29","author":"Koch","year":"2015","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0014","first-page":"1078","article-title":"Prophylactic use of a new immunosuppressive agent, deoxyspergualin, in patients with kidney transplantation from ABO-incompatible or preformed antibody-positive donors","volume":"23","author":"Takahashi","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208638","article-title":"ABO-incompatible kidney transplantation as a renal replacement therapy-a single low-volume center experience in Japan","volume":"13","author":"Kosoku","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0016","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/ajt.13502","article-title":"ABO-incompatible living kidney transplants: evolution of outcomes and immunosuppressive management","volume":"16","author":"Okumi","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0017","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(18)32091-9","article-title":"Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis","volume":"393","author":"Scurt","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0018","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.trre.2019.07.001","article-title":"Evidence-based practice: guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients","volume":"33","author":"Pascual","year":"2019","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0019","doi-asserted-by":"crossref","first-page":"190","DOI":"10.6002\/ect.2017.0200","article-title":"Pilot conversion study from mycophenolate mofetil to everolimus in stable ABO-incompatible kidney transplant recipients: analysis of 1-year follow-up data","volume":"17","author":"Uchida","year":"2019","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0020","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1093\/ndt\/gfr215","article-title":"Increase of infectious complications in ABO-incompatible kidney transplant recipients\u2013a single centre experience","volume":"26","author":"Habicht","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2021.08.062_bib0021","doi-asserted-by":"crossref","first-page":"e514","DOI":"10.1097\/TXD.0000000000000962","article-title":"One-year outcome of everolimus with standard-dose tacrolimus immunosuppression in de novo ABO-incompatible living donor kidney transplantation: a retrospective, single-center, propensity score matching comparison with mycophenolate in 42 transplants","volume":"6","author":"Noguchi","year":"2019","journal-title":"Transplant Direct"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134521009027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134521009027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:40:33Z","timestamp":1758577233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134521009027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0041134521009027"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2021.08.062","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes of Everolimus With Reduced-Dose Tacrolimus vs Mycophenolate Mofetil With Standard-Dose Tacrolimus in De Novo ABO-Incompatible Kidney Transplant Recipients: 1-Year Follow-up","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2021.08.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}